NO973198L - Aryl- og heteroarylpurinforbindelser - Google Patents

Aryl- og heteroarylpurinforbindelser

Info

Publication number
NO973198L
NO973198L NO973198A NO973198A NO973198L NO 973198 L NO973198 L NO 973198L NO 973198 A NO973198 A NO 973198A NO 973198 A NO973198 A NO 973198A NO 973198 L NO973198 L NO 973198L
Authority
NO
Norway
Prior art keywords
alkyl
alkoxy
halogen
ring
substituted
Prior art date
Application number
NO973198A
Other languages
English (en)
Other versions
NO973198D0 (no
Inventor
Franco Buzzetti
Maria Gabriella Brasca
Antonio Longo
Dario Ballinari
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9523242.7A external-priority patent/GB9523242D0/en
Priority claimed from GBGB9524131.1A external-priority patent/GB9524131D0/en
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of NO973198D0 publication Critical patent/NO973198D0/no
Publication of NO973198L publication Critical patent/NO973198L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • C07D473/30Oxygen atom attached in position 6, e.g. hypoxanthine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • C07D473/34Nitrogen atom attached in position 6, e.g. adenine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/36Sulfur atom
    • C07D473/38Sulfur atom attached in position 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Nye bicykliske, kondenserte pyrimidinforbindelser som har den generelle formel (I) (I) hvor X er -CH2-, -NH-(CH2)n-, -0-(CH2)n- eller -S-(CH2)n- hvor n er 0 eller 1; A er en 4,5-kondensert imidazolring N-substituert med R3 som er hydrogen, C1-C4 alkyl eller benzyl, eller A er en 2,3-kondensert pyridinring C-substituert med R4 som er hydrogen, C1-C4 alkyl, C1-C4 alkoksy, halogen eller NRsR^ hvor hver av R5 og R^ uavhengig er H eller C1-C4 alkyl; B er en bicyklisk ring valgt fra tetralin, indan og 2-oksindol; hver av Rj og R2 er uavhengig hydrogen, C1-C4 alkyl, halogen, hydroksy, C]-C4 alkoksy, C1-C4 alkoksykarbonyl, niuo, cyano eller CF3; og de farmasøytisk akseptable saltene derav; og hvor, når samtidig, A er pyridin og B er en tetralinring, R4 er H, C1-C4 alkyl, C1-C4 alkoksy eller halogen og X er som definert ovenfor, så er hver av Rj og R2 forskjellig fra H; og hvor, når samtidig, A er imidazol, X er -NH-(CH2)n- som definert ovenfor, og B er en indanring usubstituert eller substi- tuert med en eller flere av halogen, hydroksy, C1-C4 alkoksy og nitro, så er R3 for- skjellig fra C]-C4 alkyl eller benzyl.
NO973198A 1995-11-14 1997-07-09 Aryl- og heteroarylpurinforbindelser NO973198L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9523242.7A GB9523242D0 (en) 1995-11-14 1995-11-14 Aryl and heteroaryl purine compounds
GBGB9524131.1A GB9524131D0 (en) 1995-11-24 1995-11-24 Pyrido-pyrimidine compounds as tyrosine kinase inhibitors
PCT/EP1996/004460 WO1997018212A1 (en) 1995-11-14 1996-10-14 Aryl and heteroaryl purine compounds

Publications (2)

Publication Number Publication Date
NO973198D0 NO973198D0 (no) 1997-07-09
NO973198L true NO973198L (no) 1997-07-09

Family

ID=26308112

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973198A NO973198L (no) 1995-11-14 1997-07-09 Aryl- og heteroarylpurinforbindelser

Country Status (17)

Country Link
US (1) US5965563A (no)
EP (1) EP0802914B1 (no)
JP (1) JPH10512896A (no)
CN (1) CN1168138A (no)
AR (1) AR004320A1 (no)
AT (1) ATE201873T1 (no)
AU (1) AU7292096A (no)
BR (1) BR9607089A (no)
CA (1) CA2209598C (no)
DE (1) DE69613211T2 (no)
EA (1) EA000072B1 (no)
ES (1) ES2159760T3 (no)
HU (1) HUP9801177A3 (no)
IL (1) IL121090A0 (no)
NO (1) NO973198L (no)
PL (1) PL321296A1 (no)
WO (1) WO1997018212A1 (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112249A (en) 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
TW321649B (no) * 1994-11-12 1997-12-01 Zeneca Ltd
GB9424233D0 (en) * 1994-11-30 1995-01-18 Zeneca Ltd Quinazoline derivatives
GB9508565D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quiazoline derivative
GB9508537D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
GB9508535D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivative
AU5343096A (en) * 1995-04-27 1996-11-18 Zeneca Limited Quinazoline derivatives
GB9624482D0 (en) * 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
IL125686A (en) 1996-02-13 2002-11-10 Zeneca Ltd Quinazoline derivatives, processes for their preparation, pharmaceutical preparations containing them and their use in the manufacture of a drug with an anti-angiogenic effect and / or an effect of reducing vascular permeability
GB9603097D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline compounds
WO1997032856A1 (en) 1996-03-05 1997-09-12 Zeneca Limited 4-anilinoquinazoline derivatives
DK0892789T4 (da) 1996-04-12 2010-04-06 Warner Lambert Co Irreversible inhibitorer af tyrosin kinaser
HRP970371A2 (en) 1996-07-13 1998-08-31 Kathryn Jane Smith Heterocyclic compounds
US5866702A (en) * 1996-08-02 1999-02-02 Cv Therapeutics, Incorporation Purine inhibitors of cyclin dependent kinase 2
CA2294244A1 (en) * 1997-07-12 1999-01-21 Cancer Research Campaign Technology Limited Cyclin dependent kinase inhibiting purine derivatives
GB9800569D0 (en) 1998-01-12 1998-03-11 Glaxo Group Ltd Heterocyclic compounds
AU3951899A (en) 1998-06-19 2000-01-05 Pfizer Products Inc. Pyrrolo(2,3-d)pyrimidine compounds
PA8474101A1 (es) 1998-06-19 2000-09-29 Pfizer Prod Inc Compuestos de pirrolo [2,3-d] pirimidina
ES2295035T3 (es) 1999-07-09 2008-04-16 Glaxo Group Limited Anilinoquinazolinas como inhibidores de proteina tirosina quinasa.
US6933299B1 (en) 1999-07-09 2005-08-23 Smithkline Beecham Corporation Anilinoquinazolines as protein tyrosine kinase inhibitors
IL149034A0 (en) 1999-11-05 2002-11-10 Astrazeneca Ab Quinazoline derivatives as vegf inhibitors
AP1905A (en) 1999-12-10 2008-10-20 Pfizer Prod Inc Pyrrolo[2,3-d] Pyrimidine Compounds.
UA74370C2 (uk) 2000-06-26 2005-12-15 Пфайзер Продактс Інк. Піроло(2,3-d)піримідинові сполуки як імуносупресори
US7301023B2 (en) 2001-05-31 2007-11-27 Pfizer Inc. Chiral salt resolution
US6936620B2 (en) * 2001-12-20 2005-08-30 Bristol Myers Squibb Company Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
EP1352910A1 (en) * 2002-04-10 2003-10-15 Grünenthal GmbH New analogs of nitrobenzylthioinosine
BR0316487A (pt) 2002-11-26 2005-10-11 Pfizer Prod Inc Método todo de tratamento da rejeição de transplantes
US20050124637A1 (en) * 2003-08-15 2005-06-09 Irm Llc Compounds and compositions as inhibitors of receptor tyrosine kinase activity
WO2005073224A2 (en) 2004-01-23 2005-08-11 Amgen Inc Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer
TW200536851A (en) * 2004-01-23 2005-11-16 Amgen Inc Compounds and methods of use
ATE374202T1 (de) * 2004-06-29 2007-10-15 Gruenenthal Gmbh Neue analoga von nitrobenzylthioinosin
EP1827434B1 (en) * 2004-11-30 2014-01-15 Amgen Inc. Quinolines and quinazoline analogs and their use as medicaments for treating cancer
JO2787B1 (en) * 2005-04-27 2014-03-15 امجين إنك, Alternative amide derivatives and methods of use
JP2009521479A (ja) * 2005-12-21 2009-06-04 アボット・ラボラトリーズ 抗ウイルス化合物
ES2395386T3 (es) 2005-12-21 2013-02-12 Abbott Laboratories Compuestos antivirales
US8236950B2 (en) * 2006-12-20 2012-08-07 Abbott Laboratories Anti-viral compounds
EP2220078B1 (en) * 2007-10-29 2013-05-22 Amgen, Inc Benzomorpholine derivatives and methods of use
PT2384326E (pt) 2008-08-20 2014-06-09 Zoetis Llc Compostos de pirrolo[2,3-d]pirimidina
DE102011111400A1 (de) * 2011-08-23 2013-02-28 Merck Patent Gmbh Bicyclische heteroaromatische Verbindungen
ES2592404T3 (es) 2012-05-21 2016-11-30 Bayer Pharma Aktiengesellschaft Benzotienopirimidinas sustituidas
TW201412740A (zh) 2012-09-20 2014-04-01 Bayer Pharma AG 經取代之吡咯并嘧啶胺基苯并噻唑酮
ES2686909B1 (es) 2017-03-22 2019-08-16 Consejo Superior Investigacion Compuestos inhibidores de cdc-7 y su uso para el tratamiento de patologias neurologicas
FR3066761B1 (fr) 2017-05-23 2020-10-30 Centre Nat Rech Scient Nouveaux composes inhibiteurs des canaux ioniques

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB828522A (en) * 1956-11-02 1960-02-17 Geigy Ag J R Purine derivatives and a process for the preparation thereof
US3112192A (en) * 1960-09-19 1963-11-26 Shell Oil Co Preservation of cut flowers
AU575438B2 (en) * 1984-10-26 1988-07-28 Warner-Lambert Company N6 - substituted deoxyribose analogues of adenosines
US4751292A (en) * 1985-07-02 1988-06-14 The Plant Cell Research Institute, Inc. Adamantyl purines
DE3529497A1 (de) * 1985-08-17 1987-02-26 Boehringer Mannheim Gmbh N(pfeil hoch)6(pfeil hoch)-disubstituierte purinderivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
WO1990009178A1 (en) * 1989-01-31 1990-08-23 Whitby Research, Inc. N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists
US5034393A (en) * 1989-07-27 1991-07-23 Dowelanco Fungicidal use of pyridopyrimidine, pteridine, pyrimidopyrimidine, pyrimidopyridazine, and pyrimido-1,2,4-triazine derivatives
ES2143992T3 (es) * 1991-11-25 2000-06-01 Pfizer Derivados de 5-(hetero- o carbociclilamino)-indol, su preparacion y uso como 5-ht1 agonistas.
US5670501A (en) * 1994-09-01 1997-09-23 Discovery Therapeutics, Inc. N-substituted 9-alkyladenines

Also Published As

Publication number Publication date
JPH10512896A (ja) 1998-12-08
ATE201873T1 (de) 2001-06-15
US5965563A (en) 1999-10-12
AR004320A1 (es) 1998-11-04
NO973198D0 (no) 1997-07-09
EA199700107A1 (ru) 1997-12-30
CA2209598C (en) 2005-06-07
EP0802914B1 (en) 2001-06-06
DE69613211T2 (de) 2001-11-15
HUP9801177A2 (hu) 1998-09-28
ES2159760T3 (es) 2001-10-16
BR9607089A (pt) 1997-11-11
EA000072B1 (ru) 1998-06-25
WO1997018212A1 (en) 1997-05-22
PL321296A1 (en) 1997-12-08
EP0802914A1 (en) 1997-10-29
DE69613211D1 (de) 2001-07-12
CA2209598A1 (en) 1997-05-22
MX9705010A (es) 1997-10-31
IL121090A0 (en) 1997-11-20
CN1168138A (zh) 1997-12-17
AU7292096A (en) 1997-06-05
HUP9801177A3 (en) 1998-11-30

Similar Documents

Publication Publication Date Title
NO973198L (no) Aryl- og heteroarylpurinforbindelser
CY1117132T1 (el) Παραγωγο θειαζολιου
CA2160444A1 (en) Aroyl-piperdine derivatives
LU92113I2 (fr) Perampanel et ses dérivés pharmaceutiquement acceptables (FYCOMPA)
KR950008512A (ko) 이미다조피리딘 유도체의 제조방법
IE41539L (en) Chroman derivatives.
NO20080917L (no) Nytt heterocyklidenacetamidderivat
DE69824332D1 (de) N-Aryl-piperidinderivate und ihre Verwendung als 5-HT1B-Rezeptorliganden
YU19890A (sh) Derivati tetrahidrobenzimidazola i postupak za njihovo dobijanje
AR017189A1 (es) Antagonistas del receptor de trombina triciclico sustituido, composicion farmaceutica que lo contiene y su uso para la manufactura de un medicamento
EA199801013A1 (ru) Производные дистамицина, способ их получения и применение в качестве противоопухолевых и противовирусных агентов
ES2039221T3 (es) Procedimiento para producir derivados de piridazinona.
ATE427310T1 (de) Kondensierte bicyclische pyrimidinderivate
DE69329084D1 (de) Benzoxazepin-Derivate als Cholinesterase-Inhibitoren
PL91738B1 (no)
AR036735A1 (es) Derivados de 5-metoxi-8-aril-[1,2,4]triazolo[1,5-a]piridina
AR036734A1 (es) Derivados de 8-amino-[1,2,4]triazolo[1,5-a]piridina-6-carboxilico
IS2282B (is) Ný lyfefnasambönd með alfa2viðtakavirkni
ATE58902T1 (de) Penem-derivate.
YU11494A (sh) Postupak za dobijanje derivata piperazinilkamforsulfonila kao antagonista oksitocina
EP1496059A4 (en) CONDENSED BICYCLIC PYRIMIDINE DERIVATIVES
DE69319900D1 (de) N,n'-disubstituierte amidderivate
EA199800720A1 (ru) Гетероциклические производные эрголина в качестве лигандов 5-htia рецептора
DE69626624D1 (de) Medikamente gegen trhombocytopenie
NO955071D0 (no) abeo-Ergolin-derivater som 5HT1A-ligander